Changes of carbohydrate and lipid metafbolism and c-reactive protein in patients with ischemic heart disease and fatty hepatose

S. А. Tkachuk, H. V. Bashta, L. Ye. Lapovets, M. P. Zaletskyi


The aim of the study was to detect changes in lipid and carbohydrate metabolism and the level of C-reactive protein in patients with ischemic heart disease, combined with non-alcoholic fatty liver disease. Widespread ischemic heart disease combined with non-alcoholic fatty liver disease requires finding mutual pathogenetic mechanisms for improving the diagnosis and treatment optimization to improve the course and prognosis of these comorbid diseases. Patients with non-alcoholic fatty liver disease must be classified as high-risk population.


ischemic heart disease; non-alcoholic fatty liver disease; lipid metabolism; carbohydrate metabolism; C-reactive protein.


Miokardyt: vyznachennia, klasyfikatsiia, standarty diahnostyky ta likuvannia : metod. rek. / In-t kardiolohii im. M. D. Strazheska AMN Ukrainy, Ukr. tsentr nauk. med. inform. i patent.-litsenz. roboty ; uklad. : V. M. Kovalenko, D. V. Riabenko, N. O. Solobiukova, O. V. Onyshchenko. – Kyiv. : [b.v.], 2011. – 40 s.

Stepanov Iu. M. Klinicheskie osobennosti techeniia nealkogolnogo steatogepatita v zavisimosti ot soputstvuiushchikh zabolevanii / Iu. M. Stepanov, A. Iu. Filippova // Suchasna gastroenterologіia. – 2006. – 29, № 3. – S. 4–7.

The natural history of nonalcoholic fatty liver disease: a population-based cohort study / L. A. Adams, J. F. Lymp, J. St Sauver [et al.] // Gastroenterology. – 2005. – 129. – P. 113–121.

The diagnosis and management of nonalcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association / N. Chalasani, Z. Younossi, J. E. Lavine [et al.] // Hepatology. – 2012. – 55. – P. 2005–2023.

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States / M. R. Charlton, J. M. Burns, R. A. Pedersen [et al.] // Gastroenterology. – 2011. – 141. – P. 1249–1253.

Long-term follow-up of patients with NAFLD and elevated liver enzymes / M. Ekstedt, L. E. Franzen, U. L. Mathiesen [et al.] // Hepatology. – 2006. – 44. – P. 865–873.

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement / S. M. Grundy, J. I. Cleeman, S. R. Daniels [et al.] // Circulation. – 2005. – 112. – P. 2735–2752.

Management of nonalcoholic fatty liver disease and steatohepatitis / T. A. Le, R. Loomba // J. Clin. Exp. Hepatol. – 2012. – 2. – P. 156–173.

Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease / R. Lomonaco, C. Ortiz-Lopez, B. Orsak [et al.] // Hepatology. – 2012. – 55. – P. 1389–1397.

Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis / R. Loomba, M. Abraham, A. Unalp [et al.] // Hepatology. – 2012. – 56. – P. 943–951.

Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients / M. Noureddin, K. P. Yates, I. A. Vaughn [et al.] // Hepatology. – 2013. – 58. – P. 1644–1654.

Endpoints and clinical trial design for nonalcoholic steatohepatitis / A. J. Sanyal, E. M. Brunt, D. E. Kleiner [et al.] // Hepatology. – 2011. – 54. – P. 344–353.

Randomized trial of exercise effect on intra hepatic triglyceride content and lipid kinetics in non alcoholic fatty liver disease / S. Sullivan, E. P. Kirk, B. Mittendorfer [et al.] // Hepatology. – 2012. – 55. – P. 1738–1745.

Vernon G. Systematic review: the epidemiology and natural history of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in adults / G. Vernon, A. Baranova, Z. M. Younossi Aliment // Pharmacol. Ther. – 2011. – 34. – P. 274–285.



  • There are currently no refbacks.